
Fig. 4. Inhibition of acid secretion by bafilomycin A1 and Sch-28080.
Urinary bladders were mounted in vitro in chambers as described in Materials
and methods and the legend to Fig.
1. When the short-circuit current was stable, bafilomycin
A1 was introduced into the mucosal solution to the indicated final
concentration. When the short-circuit current again stabilized, Sch-28080 was
then added to the mucosal solution to the concentration indicated. Bars show
inhibition by each compound as a percentage of baseline acid secretion
(-4.7±1.25 µA (per area of chamber, 1.43 cm2),
N=7). *Significant effect of treatment
(P<0.01).